Serum Carnitine Level in Chronic Viral HepatitisSerum Carnitine Level in Chronic Viral Hepatitis
What is the relationship between serum carnitine levels and chronic viral hepatitis? Future Virology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 2, 2014 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Scientist recreates H1N1 flu virus RESISTANT to vaccine
Dr Yoshihiro Kawaoka, professor of virology at University of Wisconsin at Madison, has tweaked the 2009 strain of pandemic influenza to make it resistant the human immune system's antibodies. (Source: the Mail online | Health)
Source: the Mail online | Health - July 2, 2014 Category: Consumer Health News Source Type: news

Expat virologist takes to YouTube to challenge “pseudoscience” behind Egyptian devices
Military-supported devices claim to noninvasively detect viruses in blood and treat infected people (Source: ScienceNOW)
Source: ScienceNOW - June 30, 2014 Category: Science Source Type: news

Evolution of equine influenza led to canine offshoot which could mix with human influenza
(American Society for Microbiology) Equine influenza viruses from the early 2000s can easily infect the respiratory tracts of dogs, while those from the 1960s are only barely able to, according to research published ahead of print in the Journal of Virology. The research also suggests that canine and human influenza viruses can mix, and generate new influenza viruses. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 19, 2014 Category: Global & Universal Source Type: news

Leading virologists join together to tackle viruses, leukemia and neurologic disorders
(Global Virus Network) GVN announces launch of Task Force on HTLV, Human T-Lymphotropic Virus (HTLV). Experts from 11 countries, led by Dr. Robert Gallo, GVN co-founder/scientific director and director of the Institute of Human Virology at the University of Maryland School of Medicine, Dr. Luc Willems (Research Director, National Fund for Scientific Research at University of Liège) and Dr. Hideki Hasegawa (Director, Department of Pathology, National Institute of Infectious Diseases, Japan) met last month. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 17, 2014 Category: Infectious Diseases Source Type: news

Unboosted ATV vs Ritonavir-Boosted PI Maintenance TherapyUnboosted ATV vs Ritonavir-Boosted PI Maintenance Therapy
This meta-analysis compares unboosted atazanavir with ritonavir-boosted PI for long-term antiretroviral therapy in adults with virological suppression. HIV Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 10, 2014 Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news

Reverse Genetics of Influenza Virus
Reverse genetics is the creation of a virus from a full-length cDNA copy of the viral genome, referred to as an “infectious clone,” and is one of the most powerful genetic tools in modern virology. Since its development in 1999, plasmid-based reverse genetics has been effectively applied to numerous aspects of influenza studies which include revolutionizing the production of seasonal and pandemic influenza vaccine seed strains. Although continual improvement in reverse genetics system is being made in different laboratories for the efficient rescue of the influenza virus, the basic concept of synthesizing viral...
Source: Springer protocols feed by Infectious Diseases - June 6, 2014 Category: Infectious Diseases Source Type: news

Hemorrhagic Fevers Can Be Caused by Body's Antiviral Interferon Response
Virologists and immunologists have found a major clue to the mystery of “hemorrhagic fever” syndromes. The team showed that Interferon Type I immune proteins are key drivers of a viral syndrome in mice that closely mimics human hemorrhagic fevers. Hemorrhagic fevers caused by Lassa, dengue and other viruses affect more than one million people annually and are often fatal, yet scientists, until now, have never understood why only some virus-infected people come down with the disease and others do not. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 4, 2014 Category: Science Source Type: news

Hemorrhagic fevers can be caused by body's antiviral interferon response
(Scripps Research Institute) Virologists and immunologists at The Scripps Research Institute have found a major clue to the mystery of 'hemorrhagic fever' syndromes. The team showed that Interferon Type I immune proteins are key drivers of a viral syndrome in mice that closely mimics human hemorrhagic fevers. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 4, 2014 Category: Infectious Diseases Source Type: news

SLU virologists harness adenovirus to kill breast cancer cells
(Saint Louis University) Saint Louis University researcher Maurice Green, Ph.D., hopes to tame the adenovirus's ability to kill cancer cells in order to use it as a therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 23, 2014 Category: Global & Universal Source Type: news

Antiviral Vaginal Rings for Preventing HIV in WomenAntiviral Vaginal Rings for Preventing HIV in Women
Could this device be the solution to HIV prevention in women? Future Virology (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - May 21, 2014 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news

Nigeria: Lassa Fever - Ebonyi NMA Sends SoS to FG
[Independent]Abakaliki -The Nigeria Medical Association (NMA), Ebonyi State branch, rose from meeting at the Federal Teaching Hospital, Abakaliki (FETHA2), on Saturday with a call to the Federal Government to, as a matter of emergency, establish a virology diagnosis centre in the South East geo-political zone to save the inhabitants of the area from Lassa fever. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 19, 2014 Category: African Health Source Type: news

Being Creative with Sickle Cell Disease
When Cindy Hahn was a young girl, her father, a virologist, used to let her sit at his microscope and look at immune cells fighting a pig virus. Watching that pig virus sparked a passion for science she is now pursuing as an MD-PhD student. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - May 10, 2014 Category: Hospital Management Authors: Kate Villars Tags: Education News blood disease Christopher Lowrey Cindy Hahn sickle cell students Source Type: news

Keep Or Kill Last Lab Stocks Of Smallpox? Time To Decide, Says WHO
"If smallpox is outlawed, only outlaws will have smallpox," says one NIH virologist. Others say keeping vials of deadly virus just invites a horrific accident or theft. WHO is about to vote — again.» E-Mail This (Source: NPR Health and Science)
Source: NPR Health and Science - May 9, 2014 Category: Consumer Health News Source Type: news

'3D' Combination Effective for Hep C Even Without Ribavirin'3D' Combination Effective for Hep C Even Without Ribavirin
The interferon-free regimen led to high rates of sustained virologic response both with and without the addition of ribavirin. Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 9, 2014 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Middle East Respiratory Syndrome (MERS): Threats Posed by the Virus (WSJ video)
An Indiana patient with the first case of Middle East Respiratory Syndrome (MERS) reported in the U.S. is stable. But the MERS virus has proved deadly elsewhere. What kind of threat does the virus present? Columbia University's Dr. W. Ian Lipkin discusses with the WSJ:MERS was first identified in June 2012. Arabian camels were recently identified as the source of the respiratory virus. To date, there have been 401 confirmed cases of MERS in 12 countries, but all the cases originated in 6 countries in the Arabian Peninsula. More than 100 people have died. New research has confirmed that camels can transmit the deadly MERS v...
Source: Clinical Cases and Images - May 8, 2014 Category: Journals (General) Tags: Infectious Diseases WSJ Source Type: news

MERS Can Be Transmitted From Camel to Human, Study Confirms
Vienna virologists report finding coronavirus almost identical in both from same region (Source: WebMD Health)
Source: WebMD Health - May 6, 2014 Category: Consumer Health News Source Type: news

MERS Can Be Transmitted from Camel to Human, Study Confirms
Vienna virologists report finding coronavirus almost identical in both from same region Source: HealthDay Related MedlinePlus Pages: Coronavirus Infections, International Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 6, 2014 Category: Consumer Health News Source Type: news

MERS: A Virologist's View From Saudi Arabia
Surge in cases caused by increase in testing and lack of hospital hygiene, says Christian Drosten (Source: ScienceNOW)
Source: ScienceNOW - May 6, 2014 Category: Science Source Type: news

Oral HCV Regimen Continues Strong Showing (CME/CE)
CHICAGO (MedPage Today) -- An all-oral antiviral combination led to sustained virologic response in more than 90% of patients with the most common type of hepatitis C virus in North America. (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - May 5, 2014 Category: Gastroenterology Source Type: news

The Anti-Vaxxers Simply Won’t Quit
It’s never easy to say oops. You know it if you’ve ever said something nasty during an argument and found it hard to apologize later. You know it if you’ve ever caused a fender bender on the road and been unable to say “my bad.” And you know it if you’ve ever failed to inoculate your baby against a range of disabling and deadly diseases that can be easily and harmlessly prevented with vaccines, in effect failing to perform the most basic job of parenthood, which is to keep your children safe. MoreMeasles Outbreaks Have Hit 13 States This Year, CDC Says‘Are Your Children Vaccinated?...
Source: TIME: Top Science and Health Stories - May 5, 2014 Category: Science Authors: Jeffrey Kluger Tags: Uncategorized anti-vaccinators extremists measles mumps Parents polio vaccines WHO whooping cough Source Type: news

Soy sauce molecule may unlock drug therapy for HIV patients
For HIV patients being treated with anti-AIDS medications, resistance to drug therapy regimens is commonplace. Often, patients develop resistance to first-line drug therapies, such as Tenofovir, and are forced to adopt more potent medications. Virologists now are testing the next generation of medications that stop HIV from spreading, and are using a molecule related to flavor enhancers found in soy sauce, to develop compounds that are more potent than Tenofovir. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 5, 2014 Category: Science Source Type: news

Soy sauce molecule may unlock drug therapy for HIV patients
(University of Missouri-Columbia) For HIV patients being treated with anti-AIDS medications, resistance to drug therapy regimens is commonplace. Often, patients develop resistance to first-line drug therapies, such as Tenofovir, and are forced to adopt more potent medications. Virologists at the University of Missouri now are testing the next generation of medications that stop HIV from spreading, and are using a molecule related to flavor enhancers found in soy sauce, to develop compounds that are more potent than Tenofovir. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 5, 2014 Category: Biology Source Type: news

Oral HCV Regimen Continues Strong Showing
CHICAGO (MedPage Today) -- An all-oral antiviral combination led to sustained virologic response in more than 90% of patients with the most common type of hepatitis C virus (HCV) in North America. (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - May 4, 2014 Category: Gastroenterology Source Type: news

Fears Rise Over MERS Outbreak While Saudis Fumble
The sudden spike in cases of Middle East respiratory syndrome, or MERS, in Saudi Arabia came soon after camel racing events at the Jenadriyah Festival in Riyadh. That suggested the surge in the incurable coronavirus, which resembles pneumonia but is fatal to one in three who contract it, confirmed what scientists already knew of the disease: that camels seem to be reservoirs for the virus, and transmit it to humans more easily than humans do to one another. MoreSaudi Arabia Confirms 20 New Cases of Deadly MERS VirusMERS Death Toll Climbs as Man Killed By Virus in Saudi ArabiaMen Charged With Toppling Ancient Rock Formation...
Source: TIME: Top Science and Health Stories - April 22, 2014 Category: Science Authors: Karl Vick Tags: Uncategorized bird glue coronavirus H1N1 MERS middle east respiratory syndrome SARS Saudi Arabia Source Type: news

Researchers identify a new variant of Ebola virus in Guinea
In a new article, researchers have published their initial findings on the characteristics of the Ebola virus discovered in Guinea. Initial virological investigations enabled them to identify Zaire ebolavirus as the pathogen responsible for this epidemic. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 22, 2014 Category: Science Source Type: news

Inserm and the Institut Pasteur identify a new variant of Ebola virus in Guinea
(INSERM (Institut national de la santé et de la recherche médicale)) In an article which appeared in The New England journal of Medicine on 16 April, researchers from Inserm and the Institut Pasteur have published their initial findings on the characteristics of the Ebola virus discovered in Guinea. Initial virological investigations enabled them to identify Zaire ebolavirus as the pathogen responsible for this epidemic. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 22, 2014 Category: Biology Source Type: news

Community-based HIV prevention can boost testing, help reduce new infections
Communities in Africa and Thailand that worked together on HIV-prevention efforts saw not only a rise in HIV screening but a drop in new infections, according to a new study in the peer-reviewed journal The Lancet Global Health.   The U.S. National Institute of Mental Health's Project Accept — a trial conducted by the HIV Prevention Trials Network to test a combination of social, behavioral and structural HIV-prevention interventions — demonstrated that a series of community efforts boosted the number of people tested for HIV and resulted in a 14 percent reduction in new HIV infections, compared ...
Source: UCLA Newsroom: Health Sciences - April 18, 2014 Category: Universities & Medical Training Source Type: news

Community-based HIV prevention can boost testing, help reduce new infections
Communities in Africa and Thailand that worked together on HIV-prevention efforts saw not only a rise in HIV screening but a drop in new infections, according to a new study in the peer-reviewed journal The Lancet Global Health.   The U.S. National Institute of Mental Health's Project Accept — a trial conducted by the HIV Prevention Trials Network to test a combination of social, behavioral and structural HIV-prevention interventions — demonstrated that a series of community efforts boosted the number of people tested for HIV and resulted in a 14 percent reduction in new HIV infections, compared with contr...
Source: UCLA Newsroom: Health Sciences - April 14, 2014 Category: Universities & Medical Training Source Type: news

New hepatitis C drug treatment 'shows promise'
Conclusion Although designed as an RCT, the study had an analysis of drug effectiveness that becomes more like a single cohort of people receiving an active treatment, with no comparison arm. People were assigned to the five-drug combination or matching placebos for 12 weeks. During this time, the side effects in both treatment groups were monitored and these could be compared, with itching and anaemia occurring more commonly in the active treatment group. However, the double-blind drug treatment period was completed at 12 weeks and response outcomes were then assessed 12 weeks later. Twelve weeks later, the active treatm...
Source: NHS News Feed - April 14, 2014 Category: Consumer Health News Tags: Medication Medical practice Source Type: news

New hepatitis C drug treatment 'shows promise'
Conclusion Although designed as an RCT, the study had an analysis of drug effectiveness that becomes more like a single cohort of people receiving an active treatment, with no comparison arm. People were assigned to the five-drug combination or matching placebos for 12 weeks. During this time, the side effects in both treatment groups were monitored and these could be compared, with itching and anaemia occurring more commonly in the active treatment group. However, the double-blind drug treatment period was completed at 12 weeks and response outcomes were then assessed 12 weeks later. Twelve weeks later, the active treatm...
Source: NHS News Feed - April 14, 2014 Category: Consumer Health News Tags: Medication Medical practice Source Type: news

Being Creative with Sickle Cell Disease
When Cindy Hahn was a young girl, her father, a virologist, used to let her sit at his microscope and look at immune cells fighting a pig virus. The pig virus sticks in her memory; it sparked a passion for science she is now pursuing as an MD-PhD student at Dartmouth's Geisel School of Medicine. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - April 10, 2014 Category: Hospital Management Authors: derik.hertel at dartmouth.edu (Derik Hertel) Source Type: news

Leading virologists join together to address urgent viral threat
(Global Virus Network) Causing victims to suffer severe fever and pain, chikungunya virus has reached the Caribbean and South America and is predicted to soon cause outbreaks in the United States. The Global Virus Network (GVN), whose scientific director includes virologist, Dr. Robert Gallo, will announce the formation of the GVN Chikungunya Task Force. The announcement coincides with World Health Day -- April 7: Vector-borne diseases are the theme and Chikungunya is spread by vector-borne mosquitoes. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 7, 2014 Category: Biology Source Type: news

Chikungunya poised to invade the Americas
(American Society for Microbiology) A team of French and Brazilian researchers warn that chikungunya virus is poised to invade, and become epidemic in the Americas according to research published ahead of print in the Journal of Virology. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 7, 2014 Category: Infectious Diseases Source Type: news

Preparation of Herpes Simplex Virus-Infected Primary Neurons for Transmission Electron Microscopy
Transmission electron microscopy (TEM) provides the resolution necessary to identify both viruses and subcellular components of cells infected with many types of viruses, including herpes simplex virus. Recognized as a powerful tool in both diagnostic and research-based virology laboratories, TEM has made possible the identification of new viruses and has contributed to the elucidation of virus life cycle and virus–host cell interaction. (Source: Springer protocols feed by Infectious Diseases)
Source: Springer protocols feed by Infectious Diseases - April 3, 2014 Category: Infectious Diseases Source Type: news

Study fingers chickens, quail, in spread of H7N9 influenza virus
Among the copious species of poultry in China, quail and chickens are the likely sources of infection of H7N9 influenza virus to humans, according to a paper published ahead of print in the Journal of Virology."Knowing the likely poultry species lets us target our interventions better to prevent human infections," says corresponding author David Suarez, of the United States Department of Agriculture.The H7N9 avian influenza virus was first reported in humans in March 2013 in China. Since then over 375 human cases have been confirmed and over 100 have died. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 20, 2014 Category: Consumer Health News Tags: Bird Flu / Avian Flu Source Type: news

Study fingers chickens, quail, in spread of H7N9 influenza virus
(American Society for Microbiology) Among the copious species of poultry in China, quail and chickens are the likely sources of infection of H7N9 influenza virus to humans, according to a paper published ahead of print in the Journal of Virology. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 18, 2014 Category: Biology Source Type: news

Role of Human Papillomaviruses in Esophageal CarcinomaRole of Human Papillomaviruses in Esophageal Carcinoma
Studies have shown that HPV increases the risk of esophageal squamous cell carcinoma at least threefold. What impact could vaccines have on prevention? Future Virology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 11, 2014 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

New 96-Week ACTG Study Results Presented at CROI 2014; First Large Study Comparing ISENTRESS® (raltegravir) Regimen to Two Protease Inhibitor Regimens in Previously Untreated Adults with HIV-1
Dateline City: BOSTON BOSTON--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, said today that in a new 96-week, open-label AIDS Clinical Trials Group (ACTG) study designed to compare three different NNRTI-sparing HIV regimens in treatment-naïve patients – one containing Merck’s twice-daily ISENTRESS® (raltegravir) and two containing different once-daily ritonavir-boosted protease inhibitors, atazanavir and darunavir -- all three regimens achieved high and equivalent levels of efficacy, as measured by time to...
Source: Merck.com - Product News - March 5, 2014 Category: Drugs & Pharmacology Tags: Prescription Medicine News Corporate News Latest News Source Type: news

New 96-Week ACTG Study Results Presented at CROI 2014; First Large Study Comparing ISENTRESS® (raltegravir) Regimen to Two Protease Inhibitor Regimens in Previously Untreated Adults with HIV-1
Dateline City: BOSTON BOSTON--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, said today that in a new 96-week, open-label AIDS Clinical Trials Group (ACTG) study designed to compare three different NNRTI-sparing HIV regimens in treatment-naïve patients – one containing Merck’s twice-daily ISENTRESS® (raltegravir) and two containing different once-daily ritonavir-boosted protease inhibitors, atazanavir and darunavir -- all three regimens achieved high and equivalent levels of efficacy, as measured by time t...
Source: Merck.com - Research and Development News - March 5, 2014 Category: Pharmaceuticals Tags: Research and Development News Source Type: news

Dr. Gary J. Nabel
Chief Scientific Officer for SanofiDr. Nabel has an extensive and distinguished background of academic and hospital appointments, and committee memberships including numerous prestigious awards and honors and an extensive publication record. He graduated magna cum laude from Harvard College in 1975 and continued his graduate studies at Harvard University, completing his Ph.D. in 1980 and his M.D. in 1982. He served as a postdoctoral fellow in the laboratory of David Baltimore at MIT’s Whitehead Institute. Before his appointment at the Vaccine Research Center, Dr. Nabel served as the Henry Sewall Professor of Internal...
Source: PHRMA - February 28, 2014 Category: Pharmaceuticals Authors: Sabrina Source Type: news

Light zaps viruses: How photosensitization can stop viruses from infecting cells
A UCLA-led team of researchers has found evidence that photosensitizing a virus's membrane covering can inhibit its ability to enter cells and potentially lead to the development of stronger, cheaper medications to fight a host of tough viruses.   The UCLA AIDS Institute study, published in the February issue of the Journal of Virology, is part of ongoing research on a compound called LJ001, a "broad-spectrum" antiviral that can attack a wide range of microbes.   The current paper advances the science by showing that the process of photosensitization — heightening a biological organism's sens...
Source: UCLA Newsroom: Health Sciences - February 28, 2014 Category: Universities & Medical Training Source Type: news

Françoise Barré-Sinoussi: 'Ruling out a cure for Aids would not be French'
The scientist who helped discover the HIV retrovirus talks about her work and why she is convinced a cure for Aids can be foundFor Françoise Barré-Sinoussi, San Francisco holds poignant memories. The Nobel prize-winning virologist based at the Pasteur Institute in Paris is attending a conference on how to rid the world of Aids. But the city reminds her of the terrible early years of the disease. She first met a person dying from Aids in a hospital in San Francisco in 1984. "It was a very moving moment," she recalls. "He told me, 'Thank you' and I didn't understand why. So I asked and he said, '...
Source: Guardian Unlimited Science - February 15, 2014 Category: Science Authors: Zoë Corbyn Tags: Medical research Nobel prizes Society Features Aids and HIV The Observer Science Source Type: news

Long distance signals protect brain from viral infections
(American Society for Microbiology) The brain contains a defense system that prevents at least two unrelated viruses -- and possibly many more -- from invading the brain at large. The research is published online ahead of print in the Journal of Virology. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 10, 2014 Category: Infectious Diseases Source Type: news

Effects of TB Treatment on Virologic and CD4 Response to ARTEffects of TB Treatment on Virologic and CD4 Response to ART
Does TB treatment at ART initiation affect virologic and CD4 count response in HIV-infected adults? AIDS (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - January 27, 2014 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news

Daclatasvir–sofosbuvir combo effective in chronic HCV infection
Research shows that the combination of daclatasvir and sofosbuvir leads to high rates of sustained virologic response in patients with chronic hepatitis C virus infection, including those who have not responded to previous therapy. (Source: MedWire News - Gastroenterology)
Source: MedWire News - Gastroenterology - January 24, 2014 Category: Gastroenterology Source Type: news

FASEB announces 2014 Science Research Conference: Virus Structure and Assembly
(Federation of American Societies for Experimental Biology) This 2014 FASEB Science Research Conference focuses on structural virology and the application of structure to our understanding of the progression of events that are the virus lifecycle: receptor binding, entry, intracellular trafficking, uncoating, replication, assembly, and exit. Virus assembly includes the process of constructing virions and of marshaling host resources for that purpose. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 22, 2014 Category: Biology Source Type: news

Bacteria-invading virus yields new discoveries
(Florida State University) Innovative work by two Florida State University scientists that shows the structural and DNA breakdown of a bacteria-invading virus is being featured on the cover of the February issue of the journal Virology. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 10, 2014 Category: Biology Source Type: news